Biomarkers
Biomarker analysis enables you to assess a therapeutic’s efficacy, safety, and mechanism of action during the drug development process. Biomarker assays can also validate targets and identify potential toxicity. We use LC-MS/MS, single or multiplex ligand-binding assays and have a range of instruments to allow analysis of absorbance, fluorescence, and chemiluminescence output (MSD, Simoa, Tecan, and Luminex).
Expertise With Biomarkers:
Extensive Experience
We have experience with 500+ biomarkers in singleplex and multiplex formats for a wide range of disease states.
Custom Assay Solutions
360biolabs provides a diverse range of simple to highly complex biomarker assays for use across various technologies and multiple matrices, including serum, plasma, ex-vivo stimulated whole blood, urine, CSF, and tissue homogenates.
Modalities
Biomarker analysis to support large-molecule, small-molecule, cell-based, and advanced therapies throughout the drug development and clinical testing process.
Quality Compliance
Our expert team is knowledgeable in regulatory expectations for biomarker analytical validations based on the context of use.
360biolabs Bioanalytical Services
Soluble Biomarkers
Assess biological indicators of normal biological processes, disease progression, or responses to treatment interventions via our diverse platforms.
Molecular Biomarkers
Qualitatively or quantitatively measure the presence, amount, or functional activity of a target entity using qPCR or digital PCR.
Cellular Biomarkers
Our advanced platforms and extensive expertise can assess any cellular response that can be done with flow cytometry.
360biolabs has a
wide-variety of
advanced platforms.
- ELISA
- MSD-ECL
- Quanterix
- SIMOA®
- Luminex™
- Flow Cytometry
- LC-MS/MS
- qPCR
- dPCR
- ELISpot
Related Content
Pharmacodynamics
PD biomarkers are used in preclinical and clinical investigations to establish optimal dosing schedules & assess therapeutic effectiveness.
Blog: Biomarkers
Read about our experience with biomarkers in our latest blog: Biomarkers as Tools to Assess and Predict Clinical Efficacy.
BioAgilytix Global Team
Our global team provides comprehensive end-to-end bioanalytical support for all your clinical trial phases.